Research animal retirement and lifetime care, now available through Alpha Genesis. Professionally managed lifetime care for retired research primates, with expert social reintroduction into stable outdoor groups led by veterinary staff deeply experienced in laboratory-animal medicine.
Learn moreAlpha Genesis supports pharmaceutical, biotechnology, academic, government, and CRO programs with GLP and non-GLP studies on an integrated rodent-to-NHP platform, plus NHP supply, contract breeding, import and quarantine, and research-grade biological materials. Study designs are built to support submissions to major health authorities, including the FDA, EMA, MHRA, and PMDA.
More than 13,000 NHPs across three facilities, and still growing. That scale lets us fill requests of nearly any size and match animals precisely by age, sex, serology, AAV status, and stock, backed by decades of colony management.
Begin in rodents and advance into NHPs with a single partner, with no vendor handoffs or lost context along the way. Sponsors move seamlessly from rodent pharmacology, PK/PD, and biomarker work into NHP safety and efficacy studies, an integrated platform that de-risks decisions and keeps multinational development programs on one coherent timeline.
Board-certified laboratory-animal veterinarians, 24/7/365 clinical and preventive care, species-specific enrichment, behavioral management, and social housing where appropriate. Decades of large-scale colony experience make our animal care program among the most sophisticated in the industry, care that directly strengthens data quality and reproducibility, backed by AAALAC-accredited, USDA-licensed operations.
Study execution, animal supply, contract breeding, imports and quarantine, worldwide logistics, and bioproducts, all delivered under one organization. Sponsors run an entire program through a single partner, with consistent veterinary oversight and documentation from first study through final delivery. One point of accountability replaces the overhead of coordinating multiple vendors, and keeps quality and timelines consistent at every stage.
Study execution, animal resources, biospecimens, and logistics within a single organization, with veterinary oversight and documentation maintained to GLP quality standards for sponsor audit and inspection readiness across global development programs.
Rodent capabilities support early in vivo work; NHP studies support translational endpoints. Both are conducted within one integrated program, under consistent veterinary oversight, study-director continuity, and documentation that supports multinational development programs.
Pharmacology and PK/PD, toxicology and safety, infectious disease and vaccines, immunology, oncology, neuroscience, surgical models, and biospecimen collection, as GLP/IND-enabling and non-GLP study support.
Integrated rodent and NHP studies spanning discovery, translational pharmacology, and IND-enabling safety, with data and documentation built to support global regulatory submissions.
Learn moreNHP access, bioproducts, and flexible study support for grant-funded and investigator-led research, backed by board-certified veterinary care and animal-welfare standards that meet federal funding requirements.
Learn moreLong-term colony support, biodefense, infectious-disease, and vaccine research, delivered with the secure infrastructure, capacity, and documentation that multi-year federal programs demand.
Learn moreOverflow capacity, specialized in vivo support, and reliable access to purpose-bred species, giving partner CROs a dependable extension of their own preclinical capabilities.
Learn moreExceptional animal care is fundamental to excellent science, and the foundation of reliable data.
Board-certified laboratory-animal veterinarians, 24/7/365 clinical and preventive care, species-specific enrichment, behavioral management, and experienced husbandry and technical teams deliver welfare that strengthens study validity. Our program operates within AAALAC-accredited, USDA-licensed operations, with OLAW Assurance and IACUC oversight as part of a broader compliance framework.
Provide study objectives, species, study type, timeline, and regulatory context, including any global or multinational submission goals. Scientific and business-development staff will review the request and respond regarding feasibility and scheduling. We coordinate the veterinary, regulatory, and import/export documentation end to end.